Request Deal Involvement

Novo completed the acquisition of the genetics business of Benchmark Holdings for £260m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Rabobank

financial advisors

Rabobank

MHP Communications

pr advisors

MHP Communications

Evercore

financial advisors

Evercore

Deutsche Numis

financial advisors

Deutsche Numis

Deutsche Numis

brokers

Deutsche Numis

Wiersholm

legal advisors

Wiersholm

Latham & Watkins

legal advisors

Latham & Watkins

PJT Partners

financial advisors

PJT Partners

Linklaters

legal advisors

Linklaters

FGS Global

pr advisors

FGS Global

or

Principals

BENCHMARK HOLDINGS PLC (GENETICS BUSINESS)

target

BENCHMARK HOLDINGS PLC (GENETICS BUSINESS)

BENCHMARK HOLDINGS PLC

vendor

BENCHMARK HOLDINGS PLC

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite